MSB-0254
MSB-0254 is a human monoclonal antibody (mAb) targeting VEGFR2/KDR/CD309. MSB-0254 inhibits the invasion, migration, and vascular mimetic (VM) formation of U251 and primary glioma cells. MSB-0254 inhibits the growth of U251 and GL261 cell transplanted tumors. MSB-0254 reduces the expression of CD34, VEGFR2, Ki67, MMP2, MMP9, and CD34/PAS. MSB-0254 can be used in advanced solid tumors research[1].
Product Specifications
UNSPSC
12352203
Target
VEGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[MSB-0254]
References & Citations
[1]Chen S, et al. Anti-VEGFR2 monoclonal antibody (MSB0254) inhibits angiogenesis and tumor growth by blocking the signaling pathway mediated by VEGFR2 in glioblastoma. Biochem Biophys Res Commun. 2022 May 14;604:158-164.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6435887-01 0.1 mL
ROR1 (NTRKR1, dJ537F10.1, Receptor Tyrosine Kinase-like Orphan Receptor) (MaxLight 650)
Sign In for Pricing
View Details MBS6435887-02 5x 0.1 mL
ROR1 (NTRKR1, dJ537F10.1, Receptor Tyrosine Kinase-like Orphan Receptor) (MaxLight 650)
Sign In for Pricing
View Details 